Piramal Pharma announces cessation of director
(05 Feb 2026)

Back
Piramal Pharma announced the cessation of Subramanian Ramadorai (DIN: 00000002) as an independent director of the company with effect from 09 February 2026.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew